Deschamps Justine, Choffat Damien, Limacher Andreas, Righini Marc, Beer Juerg Hans, Baumgartner Christine, Hugli Olivier, Aujesky Drahomir, Méan Marie
Division of Internal Medicine, Lausanne University Hospital (CHUV), Lausanne, Cozerland.
Divison of Statistics and Methodology, CTU Bern, University of Bern, Bern, Switzerland.
J Thromb Haemost. 2023 Nov;21(11):3193-3202. doi: 10.1016/j.jtha.2023.07.022. Epub 2023 Aug 12.
We aimed to evaluate the quality of life (QoL), using patient-reported outcome measures (PROMs), in elderly patients with venous thromboembolism (VTE) and to explore whether VTE complications (recurrence, bleeding, or postthrombotic syndrome) had an impact on later QoL.
We used data from the SWIss venous Thromboembolism COhort of older patients(SWITCO65+), a prospective multicenter cohort of patients aged ≥65 years with acute, symptomatic VTE. Primary outcome was changes in QoL up to 24 months, assessed using generic (36-Item Short-Form Health Survey), with physical (PCS) and mental component score (MCS), and disease-specific (Venous Insufficiency Epidemiological and Economic Study [VEINES]-QoL, [VEINES-Sym], and Pulmonary Embolism QoL) PROMs. PROM scores ranged from 0 to 100 points, higher scores indicating a better QoL. Longitudinal latent class analysis was used to group patients with similar PCS trajectories. Repeated-measures linear regression analyses were used to assess effects of VTE complications on changes in QoL scores.
In 923 patients (median age, 75; male, 54%), 140 (15%) patients died, 97 (11%) experienced recurrent VTE, and 106 (12%) major bleeding during follow-up. Compared with patients with higher PCS trajectories, patients with lower PCS trajectories were more likely to be older, female, sicker, and less physically active. On average, generic and disease-specific QoL scores improved over time (+11% in PCS, +3% in MCS, +6% in VEINES QoL, and +16% in Pulmonary Embolism QoL at 3 months). VTE complications were always associated with significantly lower QoL scores (for VTE recurrence: PCS adjusted difference -2.57, 95% CI, -4.47 to -0.67).
Although QoL following VTE tended to improve over time, patients with VTE-related complications had lower QoL than patients without complications.
我们旨在使用患者报告结局指标(PROMs)评估老年静脉血栓栓塞症(VTE)患者的生活质量(QoL),并探讨VTE并发症(复发、出血或血栓后综合征)是否会对后期的QoL产生影响。
我们使用了瑞士老年静脉血栓栓塞症队列研究(SWITCO65+)的数据,这是一项针对年龄≥65岁的急性症状性VTE患者的前瞻性多中心队列研究。主要结局是长达24个月的QoL变化,使用通用指标(36项简短健康调查)进行评估,包括身体成分得分(PCS)和精神成分得分(MCS),以及疾病特异性指标(静脉功能不全流行病学和经济学研究[VEINES]-QoL、[VEINES-Sym]和肺栓塞QoL)PROMs。PROM得分范围为0至100分,得分越高表明QoL越好。纵向潜在类别分析用于对具有相似PCS轨迹的患者进行分组。重复测量线性回归分析用于评估VTE并发症对QoL得分变化的影响。
在923例患者(中位年龄75岁;男性占54%)中,140例(15%)患者死亡,97例(11%)发生VTE复发,106例(12%)在随访期间发生大出血。与PCS轨迹较高的患者相比,PCS轨迹较低的患者更可能年龄较大、为女性、病情较重且身体活动较少。平均而言,通用指标和疾病特异性QoL得分随时间有所改善(3个月时,PCS提高11%,MCS提高3%,VEINES QoL提高6%,肺栓塞QoL提高16%)。VTE并发症总是与显著较低的QoL得分相关(VTE复发:PCS调整差异为-2.57,95%置信区间为-4.47至-0.67)。
尽管VTE后的QoL随时间倾向于改善,但与无并发症的患者相比,有VTE相关并发症的患者QoL较低。